Skip to content
Menu

Head-to-head comparison

OurView Health vs yourEra

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #358
OurView Health

OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.

From $75/mo (lowest dose rung) sema · From $135/mo (lowest dose rung) tirz · Verified August 2026

Marked down on: A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists

vs
Ranked #18Desk pick
yourEra

A compounded desk that advertises low floors — semaglutide from $79/mo, tirzepatide from $159/mo — with the plan price behind its intake, plus a NAD+ and microdosing menu, across all 50 states.

From $79/mo sema · From $159/mo tirz · Verified August 2026

Marked down on: Compounded only — not FDA-approved and not equivalent to brand Wegovy/Ozempic or Zepbound; availability can tighten as brand shortages resolve

yourEra takes this head-to-head with the higher Desk Score, 85/100 (B) against 61/100 (C) for OurView Health. OurView Health still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

OurView Health

61/100

C

Overall

yourEra

85/100

B

Price transparency

68
90

State access

24
92

Molecule range

66
84

Onboarding speed

74
80

Support responsiveness

77
80

Licensing & trust

74
78

The spec sheet

FieldOurView HealthyourEra
SemaglutideFrom $75/molowest dose rung$75/mo (starting dose, compounded)From $79/moFrom $79/mo (a floor — yourera.com attaches no term, dose or billing cycle to it; the plan price is shown only after the intake quiz; compounded)
TirzepatideFrom $135/molowest dose rung$135/mo (starting dose, compounded)From $159/moFrom $159/mo (a floor — yourera.com attaches no term, dose or billing cycle to it; the plan price is shown only after the intake quiz; compounded)
CoverageNot listed on OurView Health's site (checked August 2026)All 50 states
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forBudget shoppers wanting low-cost compounded GLP-1 via a membership savings model.Patients drawn by a low advertised floor on both semaglutide and tirzepatide who are willing to complete the intake to learn the plan price, value an add-on NAD+ or microdosing line, and don't need brand-name or oral routes.
Desk Score61/100C85/100B

The verdict

Desk pick — yourEra

yourEra takes this head-to-head with the higher Desk Score, 85/100 (B) against 61/100 (C) for OurView Health. OurView Health still holds its ground where its strengths line up with yours.

Choose OurView Health if…

Budget shoppers wanting low-cost compounded GLP-1 via a membership savings model.

From $75/mo (lowest dose rung) sema · From $135/mo (lowest dose rung) tirz

Choose yourEra if…

Patients drawn by a low advertised floor on both semaglutide and tirzepatide who are willing to complete the intake to learn the plan price, value an add-on NAD+ or microdosing line, and don't need brand-name or oral routes.

From $79/mo sema · From $159/mo tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: OurView Health · yourEra.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.